Synopsys (SNPS) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

28.11.24 15:15 Uhr

Werte in diesem Artikel
Aktien

548,00 EUR 5,90 EUR 1,09%

Indizes

21.229,3 PKT 64,7 PKT 0,31%

19.480,9 PKT 77,0 PKT 0,40%

6.049,9 PKT 2,7 PKT 0,05%

Wall Street analysts forecast that Synopsys (SNPS) will report quarterly earnings of $3.29 per share in its upcoming release, pointing to a year-over-year increase of 3.8%. It is anticipated that revenues will amount to $1.63 billion, exhibiting an increase of 2.1% compared to the year-ago quarter.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.Bearing this in mind, let's now explore the average estimates of specific Synopsys metrics that are commonly monitored and projected by Wall Street analysts.Analysts expect 'Revenue- Maintenance and service' to come in at $249.31 million. The estimate points to a change of -10.9% from the year-ago quarter.It is projected by analysts that the 'Revenue- Total products revenue' will reach $1.38 billion. The estimate indicates a year-over-year change of +4.6%.The collective assessment of analysts points to an estimated 'Revenue by segment- Design IP' of $537.96 million. The estimate points to a change of +4.7% from the year-ago quarter.The combined assessment of analysts suggests that 'Revenue by segment- Design Automation' will likely reach $1.09 billion. The estimate suggests a change of +14.6% year over year.Analysts forecast 'Revenue- Upfront products' to reach $475.29 million. The estimate suggests a change of +5.8% year over year.The consensus among analysts is that 'Revenue- Time-based products' will reach $910.83 million. The estimate indicates a change of +4.7% from the prior-year quarter.View all Key Company Metrics for Synopsys here>>>Over the past month, shares of Synopsys have returned +2.1% versus the Zacks S&P 500 composite's +3.8% change. Currently, SNPS carries a Zacks Rank #4 (Sell), suggesting that it may underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Free: 5 Stocks to Buy As Infrastructure Spending SoarsTrillions of dollars in Federal funds have been earmarked to repair and upgrade America’s infrastructure. In addition to roads and bridges, this flood of cash will pour into AI data centers, renewable energy sources and more.In, you’ll discover 5 surprising stocks positioned to profit the most from the spending spree that’s just getting started in this space.Download How to Profit from the Trillion-Dollar Infrastructure Boom absolutely free today.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Synopsys, Inc. (SNPS): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Q4

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q4

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Synopsys Inc.

Analysen zu Synopsys Inc.

DatumRatingAnalyst
22.08.2019Synopsys BuyNeedham & Company, LLC
03.04.2019Synopsys BuyNeedham & Company, LLC
28.03.2019Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyThe Benchmark Company
DatumRatingAnalyst
22.08.2019Synopsys BuyNeedham & Company, LLC
03.04.2019Synopsys BuyNeedham & Company, LLC
28.03.2019Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyThe Benchmark Company
DatumRatingAnalyst
09.09.2015Synopsys HoldThe Benchmark Company
04.12.2008Synopsys UpgradeCitigroup Corp.
02.02.2007Synopsys neutralDA Davidson
31.01.2007Update Synopsys Inc.: NeutralDA Davidson
30.11.2006Synopsys holdDeutsche Securities
DatumRatingAnalyst
21.08.2008Synopsys DowngradeCitigroup Corp.
24.06.2005Synopsys underweightPrudential Financial

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Synopsys Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"